Drug-Drug Interaction Study to Evaluate the Effects of Ecopipam on the Pharmacokinetics of Multiple Substrates
Clinical trial NCT04764851 · TERMINATED
Trial details
- NCT number
- NCT04764851
- Sponsor
- Emalex Biosciences Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-18
- Primary completion
- 2021-04-02
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.